A Dual-Responsive Claringbullite-Like Nanozyme for Inhibition of Non-Small Cell Lung Cancer Progression.
Аннотация
A Claringbullite-like nanozyme CuCl0.38F0.1(OH)1.51•nH2O (denoted as FCN) was fabricated by a simple "one-pot" method for non-small cell lung cancer (NSCLC) treatment. Acting as an "AND" logic gate, the pH/GSH dual-responsive property allowed FCN to selectively target tumor cells while minimizing side effects. FCN exhibited the glutathione catalase (CAT)-like, peroxidase (POD)-like, and peroxidase (GPx)-like activities. The enhanced catalytic activity of FCN was attributed to its improved charge transfer capability, as evidenced by its performance in H2O2 decomposition. FCN prompted cuproptosis and ferroptosis by depriving glutathione (GSH), elevating ROS, alleviating hypoxia, and inhibiting glycolysis in A549 cells. Moreover, FCN elicited the active anti-tumor immune responses, including the macrophage phenotype transition, the elevated levels of CD8+ T cells, and the decreased levels of regulatory T (Treg) cells, thereby enhancing therapeutic efficacy against NSCLC. Furthermore, FCN treatment significantly attenuated lung metastasis in mice bearing Lewis lung carcinoma (LLC) cells. This work opens up a new avenue for the development of metal-halide nanozymes for tumor catalytic therapy.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.